Premier Biomedical Inc (BIEI) Inventory Turnover Ratio, from fourth quarter 2019 to fourth quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Premier Biomedical Inc  (BIEI)
 

Premier Biomedical Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Premier Biomedical Inc's inventory turnover ratio, the ratio that measures Premier Biomedical Inc's ability to manage its supply chain, sequentially decreased to 0.65 in the fourth quarter 2019, which does not come as a surprise, as the Premier Biomedical Inc continue to experience headwinds, which also impact its supply chain. Premier Biomedical Inc's average inventory processing period in the Dec 31 2019 quarter, has increased to 562 days, from 86 days, in the Sep 30 2019 quarter.

Within Healthcare sector 390 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1172 in the third quarter 2019, to 2099.

BIEI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Premier Biomedical Inc Market Share?

What is Inventory Turnover Ratio?




BIEI Inventory Turnover Ratio (Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Inventory Growth -49.49 % -82.78 % -82.04 % -69.88 % -69.34 %
Y / Y Cost of Sales Growth -92.07 % -62.2 % -82.73 % -65.91 % 548.27 %
Inventory Turnover Ratio (TTM) 0.65 4.26 2.12 1.5 1.31
BIEI's Total Ranking # 2099 # 1172 # 2099 # 1938 # 2163
Average inventory processing period 566 86 172 243 279
Seq. Inventory Growth -36.02 % -7.45 % -7.32 % -7.95 % -78.19 %
Seq. Cost of Sales Growth 347.07 % -5.65 % -15.16 % -97.78 % 2030.12 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 27
Healthcare Sector # 391
Overall Market # 2099

Inventory Turnover Ratio Statistics
High Average Low
4.26 1.51 0.34
(Sep 30 2019)   (Sep 30 2018)




Financial Statements
Premier Biomedical Inc's Inventories $ 0 Millions Visit BIEI's Balance sheet
Premier Biomedical Inc's Cost of Revenues TTM $ 0 Millions Visit BIEI's Income Statement
What are BIEI's Sales? Visit BIEI's Sales by Segment

Other Inventory Turnover Ratios
Premier Biomedical Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BIEI's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BIEI's Competitors
Inventory Turnover Ratio for BIEI's Suppliers
Inventory Turnover Ratio for BIEI's Customers

You may also want to know
BIEI's Sales Growth Rates BIEI's Pe Price to earnings ratio BIEI's Receivables Turnover Ratio BIEI's Stock Quote
BIEI's Net Income Growth Rates BIEI's Ps Price to Sales ratio BIEI's Sales per Employee BIEI's Asset Turnover Ratio
BIEI's Net Margin BIEI's Pb Price to Book ratio BIEI's Financial Strength Ratios BIEI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2019 Inventories at quarter ending Dec 31 2019
Earth Science Tech Inc   2.68 $ 0.416  Millions$ 0  Millions
Illumina Inc   2.68 $ 1,076.000  Millions$ 402  Millions
Merit Medical Systems Inc  2.66 $ 562.486  Millions$ 211  Millions
Cardiovascular Systems Inc   2.66 $ 52.018  Millions$ 20  Millions
Tenet Healthcare Corp  2.66 $ 822.000  Millions$ 310  Millions
China Health Industries Holdings Inc   2.62 $ 2.272  Millions$ 1  Millions
Lannett Company Inc  2.60 $ 377.476  Millions$ 145  Millions
Akorn Inc  2.59 $ 429.723  Millions$ 166  Millions
Bionano Genomics Inc   2.59 $ 6.768  Millions$ 3  Millions
Neogen Corporation  2.58 $ 222.311  Millions$ 86  Millions
Nanostring Technologies Inc   2.58 $ 44.039  Millions$ 17  Millions
Procyon Corporation  2.57 $ 1.243  Millions$ 0  Millions
China Biologic Products Holdings Inc   2.55 $ 174.667  Millions$ 68  Millions
Intuitive Surgical Inc   2.54 $ 1,368.300  Millions$ 539  Millions
Conmed Corporation  2.52 $ 430.382  Millions$ 171  Millions
Biogen Inc   2.52 $ 1,955.400  Millions$ 776  Millions
Lifeloc Technologies Inc   2.52 $ 4.816  Millions$ 2  Millions
Orgenesis Inc   2.51 $ 3.901  Millions$ 2  Millions
Teleflex Incorporated  2.51 $ 1,165.813  Millions$ 464  Millions
Qc Technologies Inc   2.50 $ 1.098  Millions$ 0  Millions
Heska Corporation  2.50 $ 68.212  Millions$ 27  Millions
Medtronic Plc  2.49 $ 9,643.000  Millions$ 3,870  Millions
Apollo Endosurgery inc   2.46 $ 25.038  Millions$ 10  Millions
Vapotherm Inc   2.46 $ 26.793  Millions$ 11  Millions
Athenex Inc   2.45 $ 69.619  Millions$ 28  Millions
Chembio Diagnostics Inc   2.43 $ 22.394  Millions$ 9  Millions
Merck and Co Inc   2.41 $ 14,112.000  Millions$ 5,848  Millions
Haemonetics Corporation  2.41 $ 515.738  Millions$ 214  Millions
Utah Medical Products Inc  2.41 $ 17.438  Millions$ 7  Millions
Orasure Technologies Inc  2.40 $ 60.022  Millions$ 25  Millions

Date modified: 2026-09-08T15:09:57+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.